Výsledky vyhledávání - "Shizhou Kang"

Akademický článek

Atezolizumab plus carboplatin and nab‐paclitaxel versus carboplatin and nab‐paclitaxel as treatments for Chinese, treatment‐naïve, stage IV, non‐squamous, non‐small‐cell lung cancer patients: A retrospective analysis

Autor: Yingkai Chen, Shizhou Kang, Ming Yan

Publikováno v: Pharmacology Research & Perspectives, Vol 10, Iss 3, Pp n/a-n/a (2022)

Abstract The IMpower trials reported significant effects of atezolizumab‐containing chemotherapies on Caucasian patients. Chinese patients differ from their Western counterparts in terms of driver mutations, etiologies, and regimen tolerance. In Ch

Externí odkaz: https://doaj.org/article/8c39bbd04c3a4e27bf26ca32527717dc

Zobrazit plný text záznamu

Atezolizumab plus carboplatin and nab-paclitaxel versus carboplatin and nab-paclitaxel as treatments for Chinese, treatment-naïve, stage IV, non-squamous, non-small-cell lung cancer patients: A retrospective analysis

Autor: Yingkai Chen, Shizhou Kang, Ming Yan

Publikováno v: Pharmacology researchperspectives. 10(3)

The IMpower trials reported significant effects of atezolizumab-containing chemotherapies on Caucasian patients. Chinese patients differ from their Western counterparts in terms of driver mutations, etiologies, and regimen tolerance. In China, atezol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d4b9c11e27991709850ae74f3ce9f6
https://pubmed.ncbi.nlm.nih.gov/35568997

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání